ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag aplastic anemia disease medicine immunology

Advances In Bone Marrow Transplantation Improve Safety
Sara Latta | Dec 7, 1997 | 8 min read
Since the first successful bone marrow transplant in 1959, thousands of patients with lethal diseases such as severe leukemia, aplastic anemia, and inherited immune deficiencies have been successfully treated with hematopoietic stem cells (HSC). But for all the success stories, transplant physicians seeking to make HSC safer and more widely available continue to grapple with the problems of a limited donor pool, graft rejection, and graft-vs.-host disease (GVHD). Bone marrow for many years was
Immune Cell–Stem Cell Cooperation
Sarthak Sinha, Jeff Biernaskie, and Waleed Rahmani | Jul 1, 2016 | 10+ min read
Understanding interactions between the immune system and stem cells could pave the way for successful stem cell–based regenerative therapies.
Top 10 Innovations 2021
2021 Top 10 Innovations
The Scientist | Dec 1, 2021 | 10+ min read
The COVID-19 pandemic is still with us. Biomedical innovation has rallied to address that pressing concern while continuing to tackle broader research challenges.
Banking on Stem Cells
Steven Reinberg(sreinberg@the-scientist.com) | Jul 17, 2005 | 6 min read
This spring Korea's Seoul National University announced plans to open a human embryonic stem cell bank.
Notebook
The Scientist Staff | Jul 7, 1996 | 7 min read
On June 14, a House Appropriations subcommittee gave some researchers cause for celebration when it surprisingly voted to remove a provision in a government spending bill that extended a ban on federal funding of human embryo research. However, their glee was short-lived. The full panel turned around on June 25 and adopted an amendment to continue the research ban. John Eppig, senior staff scientist at Jackson Laboratory in Bar Harbor, Maine, doubts that the ban will be overturned anytime soon,

Run a Search

ADVERTISEMENT